ARMI established after Founding Director, Professor Nadia Rosenthal moved from Europe’s leading life sciences lab – the European Molecular Biology Laboratory (EMBL) – to pursue her discoveries towards reversing damage in heart attacks and muscle disease.
World leading medical scientist from Victor Chang Institute, Professor Peter Currie appointed as ARMI’s Deputy Director.
ARMI officially opened, with its $153 million medical research centre based at the Monash University Clayton Campus in Victoria.
Professor Christophe Marcelle appointed as a Group Leader at the institute with a research focus on muscle stem cells.
Two new research groups commenced. First two EMBL Australia Group Leaders recruited. ARMI hosted EMBL Australia launch. ARMI was part of a national consortium awarded a $21M Australian Research Council Special Research Initiative in Stem Cell Science. Funding awarded for the ARMIRat and AquaCore infrastructure initiatives. Leadership Advisory Board formed. Outreach science programs for primary and secondary schools, BioEYES pilot launched.
Both ARMI groups from the partner network, the European Molecular Biology Laboratory, commenced and recruited their research teams. Three new group leaders McGlinn, Kaslin and Plachta commenced bringing the overall total number of research groups to 10. ARMI now has 100 people; made up of researchers, students, affiliates, core facility support and administrative personnel.
ARMI’s grant application success rate of 38% for the year was higher than the national average of just over 20%. Total income from grants was more than $4.8 million, an increase of 18% over the previous year. ARMI researchers published 53 papers (up from 26 in 2011) as well as four book chapters and one book. Highlights include papers in the high impact journals Cell and Science.
ARMI’s international linkages were further strengthened by the Systems Biology Institute’s (SBI) decision to open its first international node at Monash University. SBI Australia is hosted at ARMI. EMBL Australia launched a student travel grants program. The Australian Bioinformatics network was launched, in partnership with CSIRO and BioPlatforms Australia.
ARMI’s grant application success rate of 30% for the year was higher than the national average of around 20%. ARMI researchers published 52 papers and 1 book chapter. Highlights include papers in the high-impact journals Science, Nature Cell Biology, Nature Materials, Nature Communications and The Journal of Experimental Medicine.
Five more research Group Leaders and their teams move to ARMI. Three new group leaders were welcomed as affiliates, Prof David Haylock, Assoc Prof Andrew Laslett and Professor Susie Nilsson, who all have joint appointments at CSIRO and Monash University. At the end of 2013, the institute consisted of 194 people comprising academics and technical staff, students, administrative support and affiliate appontments.
Connections to local, national and international research grew. ARMI researchers were also involved in several large collaborative projects.
ARMI’s second five-year strategic plan was delivered, guiding the Institute from establishment into an accelerated growth phase from 2014 – 2019.
ARMI now has 16 exceptional research groups, including joint appointments with CSIRO and the Department of Anatomy and Development Biology, each one led by a scientist renowned in their field, directing a team to explore a specific research challenge.
ARMI researchers published 54 papers and one book chapter. Highlights include papers in the high-impact journals Nature, Nature Medicine, Circ Res, Cell Stem Cell, Journal of Experimental Medicine and Cell. At the end of 2014 the Institute counted 216 people comprising academics, technical staff, students, administrative support staff and affiliate appointments. A total of 39 students are associated with ARMI making up almost 20% of the total staff at the Institute.
Finalised an agreement and launched a new scientific journal in regenerative medicine. npj Regenerative Medicine is an open access, online-only journal published by ARMI in partnership with the Nature Publishing Group and demonstrates the Institute’s growing international leadership in the fast developing regenerative medicine research sector.
Founding Director, Prof Nadia Rosenthal, is appointed as Scientific Director at the prestigious Jackson Laboratory in Maine, USA. A new EMBL Australia Group Leader was recruited maintaining the total number of research group leaders at 16.
Professor Peter Currie is appointed the new Director of Research of ARMI, and replaces Founding Director, Professor Nadia Rosenthal, who has moved to the Jackson Laboratory in Maine, USA as Scientific Director.
Dr Harald Janovjak and Dr Alberto Roselló-Díez are recruited to the Institute as group leaders.
ARMI partnered with the Institute of Tissue Engineering and Regenerative Medicine (ITERM) at the Chinese University of Hong Kong in a PhD exchange program.
Monash University Academic Board approved ARMI’s new Master of Biotechnology. In addition to our existing opportunities for students, this program is another important step towards our aim of developing Australia’s future workforce in regenerative medicine and biotechnology.